MoneyWorks4Me

Supriya Lifescience informs about scrutinizer’s report

24 Apr 2025 Evaluate
Supriya Lifescience has informed that it enclosed the voting results of the business transacted by way of Postal Ballot in the prescribed format as Annexure A along with the consolidated report of the Scrutinizer issued in this regard as Annexure B. As set out in the Notice of Postal Ballot, the following resolutions have been passed with the requisite majority on April 23, 2025:  Appointment of Ganapati Dadasaheb Yadav (DIN: 02235661) as Non-Executive Independent Director of the Company (Ordinary Resolution);  Appointment of Sunil Subhash Bhagwat (DIN: 10178976) as Non-Executive Independent Director of the Company (Ordinary Resolution).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..